The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
暂无分享,去创建一个
Michael R. Speicher | Marie Tosolini | Amos Kirilovsky | Franck Pagès | Jérôme Galon | Mihaela Angelova | Bernhard Mlecnik | Gabriela Bindea | Maximilian Waldner | M. Speicher | J. Galon | Mihaela Angelova | M. Waldner | A. Obenauf | A. Kirilovsky | V. Valge-Archer | B. Mlecnik | M. Tosolini | A. Berger | F. Pagès | G. Bindea | H. Angell | T. Fredriksen | Pauline Maby | S. Church | A. Vasaturo | Anne Berger | Anna C. Obenauf | Angela Vasaturo | Viia Valge-Archer | Sarah E. Church | Helen K. Angell | Pauline Maby | Tessa Fredriksen | Stéphanie Mauger | S. Mauger
[1] Lloyd J. Old,et al. Adaptive immunity maintains occult cancer in an equilibrium state , 2007, Nature.
[2] Pornpimol Charoentong,et al. Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy , 2015, Genome Biology.
[3] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[4] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[5] Zlatko Trajanoski,et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] K. Mimori,et al. F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. , 2015, The Journal of clinical investigation.
[7] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[8] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[9] G. Dranoff,et al. Combining immunotherapy and targeted therapies in cancer treatment , 2012, Nature Reviews Cancer.
[10] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[11] T. Schumacher,et al. Neoantigens in cancer immunotherapy , 2015, Science.
[12] W. Gerald,et al. Genes that mediate breast cancer metastasis to the brain , 2009, Nature.
[13] John Quackenbush,et al. Genesis: cluster analysis of microarray data , 2002, Bioinform..
[14] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[15] Drew M. Pardoll,et al. The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.
[16] F. Marincola,et al. Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours , 2013, The Journal of pathology.
[17] Eytan Domany,et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. , 2006, Cancer research.
[18] Shung-Haur Yang,et al. FBXW7 Mutation Analysis and its Correlation with Clinicopathological Features and Prognosis in Colorectal Cancer Patients , 2015, The International journal of biological markers.
[19] Bert Vogelstein,et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.
[20] B. Vogelstein,et al. PD-1 blockade in tumors with mismatch repair deficiency. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Chris T. A. Evelo,et al. WikiPathways: building research communities on biological pathways , 2011, Nucleic Acids Res..
[22] Susumu Goto,et al. The KEGG databases at GenomeNet , 2002, Nucleic Acids Res..
[23] I. Witz. Tumor-microenvironment interactions: dangerous liaisons. , 2008, Advances in cancer research.
[24] Pornpimol Charoentong,et al. Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction , 2010, BMC Genomics.
[25] Z. Trajanoski,et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. , 2005, The New England journal of medicine.
[26] J. Galon,et al. Natural immunity to cancer in humans. , 2010, Current opinion in immunology.
[27] M. Speicher,et al. Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients , 2014, Science Translational Medicine.
[28] Zlatko Trajanoski,et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] F. Marincola,et al. A global approach to tumor immunology. , 2004, Cellular & molecular immunology.
[30] F. Garrido,et al. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer. , 2014, Cancer research.
[31] Andrew Menzies,et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.
[32] R. Schreiber,et al. The three Es of cancer immunoediting. , 2004, Annual review of immunology.
[33] Ian A. White,et al. T-bet Regulates Metastasis Rate in a Murine Model of Primary Prostate Cancer , 2004, Cancer Research.
[34] C. Melief,et al. Cancer immunology. , 2011, Current opinion in immunology.
[35] F. Bertucci,et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters , 2004, Oncogene.
[36] M. Neurath,et al. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies , 2008, Expert review of anticancer therapy.
[37] Jérôme Galon,et al. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. , 2013, Immunity.
[38] Jack D Bui,et al. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? , 2007, Current opinion in immunology.
[39] J. Galon,et al. The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. , 2007, Cancer research.
[40] Z. Trajanoski,et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.
[41] S. Gruber,et al. Smoking, Gender, and Ethnicity Predict Somatic BRAF Mutations in Colorectal Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[42] Thomas Kirchner,et al. Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.
[43] X. Bian,et al. CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer , 2014, Clinical Cancer Research.
[44] L. Terracciano,et al. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. , 2010, International journal of oncology.
[45] Zlatko Trajanoski,et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. , 2010, Gastroenterology.
[46] Martin A. Nowak,et al. Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.
[47] R. Schreiber,et al. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.
[48] Bernhard Mlecnik,et al. CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data , 2013, Bioinform..
[49] Pornpimol Charoentong,et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..
[50] E. Jaffee,et al. Cancer immunologists and cancer biologists: why we didn't talk then but need to now. , 2007, Cancer research.
[51] Paula D. Bos,et al. Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.
[52] Lincoln Stein,et al. Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..
[53] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[54] D. Morrison,et al. FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4 , 2013, Nature Communications.
[55] J. Galon,et al. From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer. , 2013, Current opinion in immunology.
[56] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[57] I. Fidler,et al. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. , 2007, Endocrine reviews.
[58] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[59] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.